Cytokinetics, Incorporated
CYTK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$306 | -$134 | -$161 | -$150 |
| Dep. & Amort. | $3 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $31 | $28 | $24 | $0 |
| Change in WC | $23 | -$51 | -$5 | $42 |
| Other Non-Cash | $143 | $27 | $9 | $40 |
| Operating Cash Flow | -$108 | -$128 | -$132 | -$66 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$4 | -$6 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$335 | -$218 | -$164 | -$121 |
| Inv. Sales/Matur. | $274 | $280 | $276 | $233 |
| Other Inv. Act. | $0 | -$5 | $0 | $0 |
| Investing Cash Flow | -$71 | $53 | $106 | $111 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $324 | -$3 | -$3 | -$3 |
| Stock Issued | -$14 | $7 | $8 | $6 |
| Stock Repurch. | $21 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $74 | -$0 | -$1 |
| Financing Cash Flow | $330 | $79 | $5 | $2 |
| Forex Effect | $0 | -$1 | -$0 | $0 |
| Net Chg. in Cash | $152 | $2 | -$21 | $48 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $77 | $74 | $95 | $47 |
| End Cash | $229 | $77 | $74 | $95 |
| Free Cash Flow | -$117 | -$132 | -$137 | -$67 |